Anchors
| Anchor text | Ref. domains ▾ | Top DR | Ref. pages | Links to target | Dofollow links |
|---|---|---|---|---|---|
| Testbiotech | 11 | — | 0 | 15 | 15 100% |
| come under fire | 3 | — | 0 | 3 | 3 100% |
| www.testbiotech.org | 3 | — | 0 | 6 | 6 100% |
| manipulation of findings | 3 | — | 0 | 3 | 3 100% |
| 2 | — | 0 | 97 | 97 100% | |
| Table des différences entre la mutagénèse aléatoire et la mutagénèse dirigée (anglais ou allemand) - Testbiotech 2018 | 2 | — | 0 | 13 | 13 100% |
| TestBiotech | 2 | — | 0 | 4 | 4 100% |
| Weiterlesen | 1 | — | 0 | 1 | 1 100% |
| control | 1 | — | 0 | 2 | 2 100% |
| La description complète du projet RAGES | 1 | — | 0 | 1 | 1 100% |
| Postkarten an Ursula von der Leyen | 1 | — | 0 | 1 | 1 100% |
| Testbiotech: Hornlose Gentechnik-Rinder: Fehler im Erbgut übersehen (06.08.2019) | 1 | — | 0 | 1 | 1 100% |
| Testbiotech: Synthetische Gentechnik und CRISPR-Cas – die Risiken im Überblick (September 2017) | 1 | — | 0 | 1 | 1 100% |
| владеет многими патентами | 1 | — | 0 | 1 | 1 100% |
| Informe de Testbiotech (pdf) | 1 | — | 0 | 1 | 1 100% |
| Testbiotech background on NGT rice | 1 | — | 0 | 1 | 1 100% |
| Umfangreiche Belege dazu finden sich in Testbiotech Hintergrund: Golden-Rice - PR Kampagne ohne Glaubwürdigkeit (Januar 2014, Kapitel 3.2) | 1 | — | 0 | 1 | 1 100% |
| Spoločné vyhlásenie vedcov k novým GMO | 1 | — | 0 | 1 | 1 100% |
| https://www.testbiotech.org/en/news/ai-designed-viruses-created-for-the-first-time/ | 1 | — | 0 | 2 | 2 100% |
| Testbiotech: Klonen von Nutztieren – eine ‚todsichere‘ Anwendung? (Mai 2010) | 1 | — | 0 | 1 | 1 100% |
| The risks of New GE techniques | 1 | — | 0 | 1 | 1 100% |
| here | 1 | — | 0 | 1 | 1 100% |
| http://www.testbiotech.org/en/node/631 | 1 | — | 0 | 2 | 2 100% |
| Testbiotech: Erstes europäisches Patent auf CRISPR-Schweine erteilt (06.05.2024) | 1 | — | 0 | 1 | 1 100% |
| Testbiotech: Warum Pflanzen aus Neuer Gentechnik nicht dereguliert werden dürfen (Juli 2025) | 1 | — | 0 | 1 | 1 100% |
| article | 1 | — | 0 | 1 | 1 100% |
| Testbiotech: CRISPR-Rinder in den USA zugelassen (21.03.2022) | 1 | — | 0 | 1 | 1 100% |
| Pressemitteilung | 1 | — | 0 | 1 | 1 100% |
| https://www.testbiotech.org/wp-content/uploads/2024/04/Rede_Dr-Christoph-Then_26-04-2024-2.pdf | 1 | — | 0 | 1 | 1 100% |
| patentov | 1 | — | 0 | 1 | 1 100% |
| https://www.testbiotech.org/aktuelles/ngt-pflanzen-efsa-uebersah-extrem-wirkungsvolle-und-risikoreiche-anwendungen/ | 1 | — | 0 | 1 | 1 100% |
| Verein Testbiotech | 1 | — | 0 | 1 | 1 100% |
| Off-target unanticipated events | 1 | — | 0 | 1 | 1 100% |
| https://www.testbiotech.org/aktuelles/testbiotech-fordert-ende-des-anbaus-von-gentechnik-mais-mon810/ | 1 | — | 0 | 1 | 1 100% |
| “Could just one NGT company take control of all plant breeding?” | 1 | — | 0 | 1 | 1 100% |
| 1 | — | 0 | 1 | 1 100% | |
| présence | 1 | — | 0 | 1 | 1 100% |
| Testbiotech: Transgene Zierfische in Brasilien außer Kontrolle (15.02.2022) | 1 | — | 0 | 1 | 1 100% |
| Testbiotech: Einsatz der Neuen Gentechnik bei landwirtschaftlich genutzten Wirbeltieren: eine kritische Bewertung (März 2025) | 1 | — | 0 | 1 | 1 100% |
| Testbiotech: Einsatz der Neuen Gentechnik bei landwirtschaftlich genutzten Wirbeltieren – eine kritische Bewertung (März 2025) | 1 | — | 0 | 1 | 1 100% |
| den gesamten Artikel hier lesen … | 1 | — | 0 | 1 | 1 100% |
| Testbiotech e. V. – Institute for Independent Impact Assessment in Biotechnology | 1 | — | 0 | 1 | 1 100% |
| « NGT plant developers take over the EFSA GMO panel » | 1 | — | 0 | 1 | 1 100% |
| Christoph Then | 1 | — | 0 | 1 | 1 100% |
| Website link to this text | 1 | — | 0 | 1 | 1 100% |
| @media only screen and (min-device-pixel-ratio:1.5),only screen and (min-resolution:192dpi){.td-thumb-css.tdi_71{background-image:url("https://www.green-connect.de/wp-content/uploads/2023/03/Externer-Link-DE-Load-3-218x150-1.png")!important}} | 1 | — | 0 | 1 | 1 100% |
| Testbiotech: Agro-Gentechnik - zwischen hohen Erwartungen und komplexen Risiken (März 2023) | 1 | — | 0 | 1 | 1 100% |
| Ekologická spoločnosť Nemecka, Rakúska a Švajčiarska (GFÖ) | 1 | — | 0 | 1 | 1 100% |
| https://www.testbiotech.org/en/news/genome-edited-plants-negative-effects-ecosystems-are-possible | 1 | — | 0 | 1 | 1 100% |
| Mitmachaktion | 1 | — | 0 | 2 | 2 100% |
Frequently Asked Questions
What anchor texts are used to link to testbiotech.org?
This page shows all anchor texts found in backlinks pointing to testbiotech.org, sorted by the number of referring domains using each anchor. Anchor texts range from branded terms (like the domain name itself) to keyword-rich phrases that describe the linked content. The distribution of anchor texts reveals how other websites perceive and describe testbiotech.org.
What is anchor text?
Anchor text is the visible, clickable text in a hyperlink. Search engines use anchor text as a signal to understand what the linked page is about. For example, if many sites link to a page using the anchor text "best running shoes," search engines infer that the page is relevant to that topic. Anchor text appears in several forms: exact-match (contains target keywords), branded (uses the company or domain name), generic (like "click here"), and naked URLs.
Why is anchor text analysis important for SEO?
Anchor text analysis helps identify potential SEO risks and opportunities. A natural backlink profile has diverse anchor texts including branded terms, generic phrases, and topic-relevant keywords. Over-optimization, where too many backlinks use the same exact-match keyword anchor, can trigger search engine penalties. Conversely, understanding which anchors drive the most authority (measured by referring domain count and DR) helps prioritize link building efforts.
How many unique anchor texts does testbiotech.org have?
The anchor text report for testbiotech.org displays all distinct anchor texts grouped by their hash. Each row shows how many unique referring domains use that anchor, the total number of links, and the dofollow percentage. A high number of unique anchors generally indicates a healthy, natural backlink profile with diverse link sources.